Dragon

Mar 1, 2018

Approved Stamp 400

Lantheus wins FDA approval for tau PET imaging agent

August 14, 2026

Nominations Are Open — 2026 Minnies

Nominations Are Open — 2026 Minnies

August 6, 2026

Shown is a 69-year-old man with a cholangiocarcinoma in the distal common bile duct. F-18 FDG-PET/CT was negative where Ga-68 FAPI-46 PET/CT showed high focal FAPI uptake in the liver hilum and surrounding lymph nodes. a-d: F-18 FDG-PET/CT, e-h: Ga-68 FAPI-46 PET/CT. a, b, e, f: Maximum intensity projections, c, g: axial fusion images, d, h: non-contrast enhanced CT.

FAPI-PET/CT shows promise in hepatopancreatobiliary cancers

August 13, 2026

Longitudinal DBT could help improve long-term cancer risk prediction

August 13, 2026

Lantheus wins FDA approval for tau PET imaging agent

By AuntMinnie.com staff writers

Tauklarify, previously known as MK-6240, has been approved for tau PET imaging in adults with cognitive impairment being evaluated for Alzheimer's disease.

August 14, 2026

Approved Stamp 400

Women's Imaging MinnieCast, Episode 15: BACs and heart disease risk

By Amerigo Allegretto

Laurie Margolies, MD, shares insights on how breast arterial calcifications (BACs) on mammograms should be managed.

August 14, 2026

Minnie Cast Thumbnail (19)

FAPI-PET/CT shows promise in hepatopancreatobiliary cancers

FAPI-PET/CT could potentially improve noninvasive cancer staging, and, ultimately, clinical decision making.

August 13, 2026

Shown is a 69-year-old man with a cholangiocarcinoma in the distal common bile duct. F-18 FDG-PET/CT was negative where Ga-68 FAPI-46 PET/CT showed high focal FAPI uptake in the liver hilum and surrounding lymph nodes. a-d: F-18 FDG-PET/CT, e-h: Ga-68 FAPI-46 PET/CT. a, b, e, f: Maximum intensity projections, c, g: axial fusion images, d, h: non-contrast enhanced CT.

Longitudinal DBT could help improve long-term cancer risk prediction

By Amerigo Allegretto

A longitudinal DBT model outperformed other models based on mammography and clinical factors in predicting five-year cancer risk.

August 13, 2026

SBRT for prostate cancer cuts side effects, falls short on disease control

A multinational team evaluated SBRT against moderately hypofractionated intensity-modulated radiation therapy in a phase III trial.

August 13, 2026

Prostate Imaging

DEXA reveals tea consumption supports bone health

Moderate-frequency tea consumption was associated with better bone mineral status and more favorable longitudinal changes.

August 12, 2026

Adobe Stock 285124452

AI tools may not meet breast radiologists' expectations in practice

By Amerigo Allegretto

AI tools in breast imaging may have more modest clinical impact on recall and biopsy rates.

August 12, 2026

Breast Mammo Computer 400 (3)

Stepped reminders boost CT lung cancer screening

Trial findings directly address the current lack of effective lung cancer screening interventions.

August 11, 2026

Model confidence, reader expertise affect reader-LLM collaboration

By Amerigo Allegretto

Successful human-LLM collaboration is associated with model confidence and reader expertise in chest imaging.

August 11, 2026

Example cases illustrate the double-edged role of large language model (LLM) rationale quality. (A) A 50-year-old female patient with a palpable anterior chest wall mass (correct diagnosis: solitary fibrous tumor of the pleura). The LLM incorrectly suggested synovial sarcoma but provided a persuasive rationale (quality score: 4 of 5), describing a well-defined nodule at axial contrast-enhanced CT spanning the pleura and intercostal space with heterogeneous strong enhancement. Four of five readers (80%) accepted the incorrect suggestion. FDG = fluorodeoxyglucose. (B) A 61-year-old male patient with diabetes presented with cough, sputum, and dyspnea (correct diagnosis: mucormycosis). The LLM correctly suggested mucormycosis with an excellent rationale (quality score: 5 of 5), integrating the reverse halo sign on serial axial CT images and rapidly progressive cavitary lesions. Three of five readers initially selected incorrect diagnoses; after LLM output, all five selected the correct diagnosis (100% acceptance). Blue and orange reader icons denote high- and low-expertise readers, respectively.

PET/CT predicts response to neoadjuvant therapy in breast cancer

Monitoring neoadjuvant therapy response in HER2-positive breast cancer is challenging with existing tools.

August 11, 2026

Ga-68 HER2-PET/CT images before neoadjuvant therapy, at end of second cycle, and before surgery. (A) Baseline scan demonstrated soft-tissue lesion measuring approximately 2.3 × 2.2 cm in upper outer quadrant of left breast, with marked radiotracer uptake and SUVmax of 10.1. (B) At end of second cycle, imaging revealed residual lesion of approximately 2.2 × 1.0 cm in same region, without abnormal radiotracer accumulation. (C) Preoperative imaging demonstrated further reduction in lesion size to approximately 2.0 × 0.6 cm, with no abnormal tracer uptake detected.

5 factors that led to California workplace MRI accident

What happened at a Redwood City hospital in California in 2023.

August 11, 2026

The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails

NME breast lesions have high malignancy rate on MRI-guided biopsy

By Amerigo Allegretto

Biopsies from women with a known ipsilateral malignancy have a higher frequency of breast cancer.

August 10, 2026

Page 1 of 244